Home›Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd›Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd + Lopinavir

Does Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd Interact with Lopinavir?

Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd and Lopinavir have a unknown drug interaction according to U.S. FDA drug labeling data. Antiretrovirals: Protease inhibitors (PIs) Clinical Impact: Studies have shown some antiretroviral protease inhibitors (PIs) with CYP3A4 inhibitory activity (nelfinavir, lopinavir/ritonavir, ritonavir) have little effect on buprenorphine pharmacokinetic and no significant pharmacodynamic effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd and your doctor is considering prescribing Lopinavir (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd(Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate)+💊 Lopinavir(Kaletra)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
—
Source
FDA drug label - buprenorphine hydrochloride and naloxone hydrochloride dihydrate

What this means in plain English

Antiretrovirals: Protease inhibitors (PIs) Clinical Impact: Studies have shown some antiretroviral protease inhibitors (PIs) with CYP3A4 inhibitory activity (nelfinavir, lopinavir/ritonavir, ritonavir) have little effect on buprenorphine pharmacokinetic and no significant pharmacodynamic effects.

About Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd and Lopinavir

Lopinavir is also sold under the brand name Kaletra. Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd is dissolved under the tongue.

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

FDA

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihyd and Lopinavir against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.